(Q48312103)

10 February 2018

title

MGMT prognostic impact on glioblastoma is dependent on therapeutic modalities (English)

1 reference

10 February 2018

Alexandra Benouaich-Amiel

1 reference

6

object named as

Alexandra Benouaich-Amiel

1 reference

10 February 2018

5

Nathalie Auger

1 reference

10 February 2018

author name string

Emmanuelle Crinière

1

1 reference

10 February 2018

Gentian Kaloshi

2

1 reference

10 February 2018

Florence Laigle-Donadey

3

1 reference

10 February 2018

Julie Lejeune

4

1 reference

10 February 2018

Sibille Everhard

7

1 reference

10 February 2018

Karima Mokhtari

8

1 reference

10 February 2018

Marc Polivka

9

1 reference

10 February 2018

Jean-Yves Delattre

10

1 reference

10 February 2018

Khê Hoang-Xuan

11

1 reference

10 February 2018

Joëlle Thillet

12

1 reference

10 February 2018

Marc Sanson

13

1 reference

10 February 2018

publication date

12 January 2007

1 reference

10 February 2018

Journal of Neuro-Oncology

published in

1 reference

10 February 2018

volume

83

1 reference

10 February 2018

issue

2

1 reference

10 February 2018

page(s)

173-179

1 reference

10 February 2018

https://scigraph.springernature.com/pub.10.1007/s11060-006-9320-0

exact match

0 references

cites work

Glioblastomas with an oligodendroglial component: a pathological and molecular study.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11060-006-9320-0

O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells

21 January 2018

1 reference

12 December 2020

Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedules

1 reference

12 December 2020

Killing and mutagenic actions of dacarbazine, a chemotherapeutic alkylating agent, on human and mouse cells: effects of Mgmt and Mlh1 mutations

1 reference

12 December 2020

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials

1 reference

12 December 2020

p53 is involved in regulation of the DNA repair gene O6-methylguanine-DNA methyltransferase (MGMT) by DNA damaging agents

1 reference

12 December 2020

CpG island hypermethylation of the DNA repair enzyme methyltransferase predicts response to temozolomide in primary gliomas

1 reference

12 December 2020

A prospective study of cognitive functions following conventional radiotherapy for supratentorial gliomas in young adults: 4-year results.

1 reference

12 December 2020

Inverse correlation between the expression of O6-methylguanine-DNA methyl transferase (MGMT) and p53 in breast cancer

1 reference

12 December 2020

Roles of MGMT and MLH1 proteins in alkylation-induced apoptosis and mutagenesis

1 reference

12 December 2020

Promoter Hypermethylation of the DNA Repair Gene O6‐Methylguanine‐DNA Methyltransferase is an Independent Predictor of Shortened Progression Free Survival in Patients with Low‐grade Diffuse Astrocytomas

1 reference

12 December 2020

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

1 reference

12 December 2020

Loss of expression of DNA repair enzymes MGMT, hMLH1, and hMSH2 during tumor progression in gastric cancer

1 reference

12 December 2020

The effects of sequential versus concurrent chemotherapy and radiotherapy on survival and toxicity in patients with newly diagnosed high-grade astrocytoma

1 reference

12 December 2020

Predicting lung cancer by detecting aberrant promoter methylation in sputum

1 reference

12 December 2020

O(6)-methylguanine-DNA methyltransferase gene (MGMT) expression in human glioblastomas in relation to patient characteristics and p53 accumulation

1 reference

12 December 2020

Detecting homozygous deletions in the CDKN2A(p16(INK4a))/ARF(p14(ARF)) gene in urinary bladder cancer using real-time quantitative PCR.

1 reference

12 December 2020

Tumor progression through epigenetic gene silencing of O(6)-methylguanine-DNA methyltransferase in human biliary tract cancers.

1 reference

12 December 2020

O6-methylguanine-DNA methyltransferase methylation and TP53 mutation in malignant astrocytomas and their relationships with clinical course

1 reference

12 December 2020

Prognostic impact of molecular markers in a series of 220 primary glioblastomas.

1 reference

12 December 2020

Olig2 expression, GFAP, p53 and 1p loss analysis contribute to glioma subclassification

1 reference

12 December 2020

Induction of the alkyltransferase (MGMT) gene by DNA damaging agents and the glucocorticoid dexamethasone and comparison with the response of base excision repair genes.

1 reference

12 December 2020

MGMT gene silencing and benefit from temozolomide in glioblastoma

1 reference

12 December 2020

O6-methylguanine-DNA methyltransferase-deficient phenotype in human gliomas: frequency and time to tumor progression after alkylating agent-based chemotherapy

1 reference

12 December 2020

Correlation of clinical features and methylation status of MGMT gene promoter in glioblastomas

1 reference

12 December 2020

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

12 December 2020

10.1007/S11060-006-9320-0

Identifiers

DOI

1 reference

10 February 2018

release_2lcj4rt74vaenm6sqi3eimjjja

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2lcj4rt74vaenm6sqi3eimjjja

24 November 2022

mapped directly with Wikidata item

1 reference

10 February 2018